![]() |
|
G. Cayla (1), P. Sié (2), J. Silvain (1), D. Brugier (1), J.-P. Cambou (3), D. Thomas (1), A. Pena (1), S. A. O’Connor (1), A. Bura (3), J.-B. Ruidavets (4), G. Montalescot (1), J.-P. Collet (1)
(1) Institut de Cardiologie, INSERM_UMR_937, Pitié-Salpêtrière University Hospital (AP-HP), Université Paris 6, Paris, France; (2) Toulouse Laboratory of Haematology, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC) INSERM 1048, CHU de Toulouse and Université Paul Sabatier, Toulouse, France; (3) University of Toulouse, Rangueil University Hospital, Dept. of Vascular Medicine, Toulouse, France; (4) Department of Epidemiology, Health Economics and Public Health, UMR 558 INSERM, Université de Toulouse, CHU de Toulouse, Toulouse, France
It was the objective of this study to assess the effect of the implementation of the smoke-free legislation on haemostasis and systemic inflammation in second-hand smoking (SHS)-exposed healthy volunteers. Fibrin-rich clot properties, platelet reactivity and inflammatory biomarkers were measured before and four months following the implementation of the smoke-free legislation in gender and age-matched healthy volunteers exposed (n=23, exposed) and unexposed (n=23, controls) to occupational SHS. The primary objective was to compare fibrin-rich clot stiffness before and after implementation of the smoke-free legislation. There was 40% reduction in fibrin-rich clot stiffness following the implementation of the smoke-free legislation in SHS-exposed volunteers (17 ± 7 vs. 10.6 ± 7 dynes/cm², before and after, respectively, p=0.001). These dramatic changes were associated with a 20% reduction in fibrin fiber density (p<0.01) and a 20% reduction in clot lysis time (p=0.05). No change in fibrin properties was observed in the control group of SHS-unexposed volunteers related to the implementation of the smoke-free legislation. Of interest, neither platelet reactivity nor systemic inflammatory biomarkers were changed in either group. The smoke-free legislation is associated with significant changes in fibrin-rich clot properties toward a less thrombogenic conformation with a better fibrinolysis response while neither platelet reactivity nor systemic inflammatory biomarkers are modified. These improvements may explain the observed reduction in acute coronary syndrome following the implementation of the smoke-free legislation.
platelet reactivity, Second hand smoke, smoke-free legislation, fibrin-clot, inflammatory biomarkers
| 1. | ||
Francesca Cesari1, Rossella Marcucci1, Roberto Caporale2, Rita Paniccia1, Eloisa Romano1, Gian Franco Gensini3, Rosanna Abbate1, Anna Maria Gori1 Thrombosis and Haemostasis 2008 99 5: 930-935 http://dx.doi.org/10.1160/TH08-01-0002 | ||
| 2. | ||
Thomas Cuisset1, Corinne Frere2, Jacques Quilici1, Pierre-Emmanuel Morange2, Lyassine Nait-Saidi1, Thrombosis and Haemostasis 2007 97 2: 282-287 http://dx.doi.org/10.1160/TH06-07-0362 | ||
| 3. | ||
N. J. Breet (1, 2), J. W. van Werkum (1, 2), H. J. Bouman (1, 2), J. C. Kelder (1, 2), C. M. Hackeng (1, 3), J. M. ten Berg (1, 2) Thrombosis and Haemostasis 2011 106 2: 331-336 http://dx.doi.org/10.1160/TH10-08-0528 | ||